Viewing Study NCT01369433


Ignite Creation Date: 2025-12-25 @ 3:04 AM
Ignite Modification Date: 2025-12-26 @ 1:43 AM
Study NCT ID: NCT01369433
Status: TERMINATED
Last Update Posted: 2020-09-01
First Post: 2010-03-04
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: A Rollover Protocol to Allow Continued Access to Tivozanib (AV 951) for Subjects Enrolled in Other Tivozanib Protocols
Sponsor: AVEO Pharmaceuticals, Inc.
Organization: